The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Carbapenem resistance in Acinetobacter baumannii , and their importance in hospital‐acquired infections: a scientific review
Abstract
Carbapenem is an important therapy for serious hospital-acquired infections and for the care of patients affected by multidrug-resistant organisms, specifically Acinetobacter baumannii; however, with the global increase of carbapenem-resistant A. baumannii, this pathogen has significantly threatened public health. Thus, there is a pressing need to better understand this pathogen in order to develop novel treatments and control strategies for dealing with A. baumannii. In this review, we discuss an overview of carbapenem, including its discovery, development, classification and biological characteristics, and its importance in hospital medicine especially in critical care units. We also describe the peculiarity of bacterial pathogen, A. baumannii, including its commonly reported virulence factors, environmental persistence and carbapenem resistance mechanisms. In closing, we discuss various control strategies for overcoming carbapenem resistance in hospitals and for limiting outbreaks. With the appearance of strains that resist carbapenem, the aim of this review is to highlight the importance of understanding this increasingly problematic healthcare-associated pathogen that creates significant concern in the field of nosocomial infections and overall public health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1789 · Cited by 1,828
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Uncovering the mechanisms of Acinetobacter baumannii virulence
Harding, C. M., Hennon, S. W., & Feldman, M. F. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.148 · Cited by 1,026
Lee, C.-R., Lee, J. H., Park, M., Park, K. S., Bae, I. K., Kim, Y. B., Cha, C.-J., Jeong, B. C., & Lee, S. H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00055 · Cited by 1,016
Acinetobacter baumannii: evolution of a global pathogen
Antunes, L. C. S., Visca, P., & Towner, K. J. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12125 · Cited by 925
What is antimicrobial stewardship?
Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.026 · Cited by 870
Acinetobacter baumannii: An emerging opportunistic pathogen
Howard, A., O’Donoghue, M., Feeney, A., & Sleator, R. D. (2012) · Virulence · doi:10.4161/viru.19700 · Cited by 837
Carbapenem Resistance: A Review
Codjoe, F., & Donkor, E. (2017) · Medical Sciences · doi:10.3390/medsci6010001 · Cited by 746
Carbapenem resistance: overview of the problem and future perspectives
Meletis, G. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115621709 · Cited by 725
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
Comparative Review of the Carbapenems
Zhanel, G. G., Wiebe, R., Dilay, L., Thomson, K., Rubinstein, E., Hoban, D. J., Noreddin, A. M., & Karlowsky, J. A. (2007) · Drugs · doi:10.2165/00003495-200767070-00006 · Cited by 652
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 652
Multidrug resistant Acinetobacter
Manchanda, V., Sanchaita, S., & Singh, N. (2010) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.68538 · Cited by 555
Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
Hamidian, M., & Nigro, S. J. (2019) · Microbial Genomics · doi:10.1099/mgen.0.000306 · Cited by 465
New antibiotics for bad bugs: where are we?
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-22 · Cited by 403
Kempf, M., & Rolain, J.-M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.10.004 · Cited by 389
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Gordon, N. C., & Wareham, D. W. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.024 · Cited by 378
Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
Almasaudi, S. B. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2016.02.009 · Cited by 365
Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside
Lin, M.-F. (2014) · World Journal of Clinical Cases · doi:10.12998/wjcc.v2.i12.787 · Cited by 357
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Hsu, L.-Y., Apisarnthanarak, A., Khan, E., Suwantarat, N., Ghafur, A., & Tambyah, P. A. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-16 · Cited by 339
Asif, M., Alvi, I. A., & Rehman, S. U. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s166750 · Cited by 333
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
Murray, G., Peleg, A., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1398388 · Cited by 316
Zavascki, A. P., Carvalhaes, C. G., Picão, R. C., & Gales, A. C. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.108 · Cited by 312
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
Vázquez-López, R., Solano-Gálvez, S. G., Juárez Vignon-Whaley, J. J., Abello Vaamonde, J. A., Padró Alonzo, L. A., Rivera Reséndiz, A., Muleiro Álvarez, M., Vega López, E. N., Franyuti-Kelly, G., Álvarez-Hernández, D. A., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9040205 · Cited by 296
Transformation of Acinetobacter calco-aceticus ( Bacterium anitratum )
Juni, E., & Janik, A. (1969) · Journal of Bacteriology · doi:10.1128/jb.98.1.281-288.1969 · Cited by 275
Rationalizing antimicrobial therapy in the ICU: a narrative review
Timsit, J.-F., Bassetti, M., Cremer, O., Daikos, G., de Waele, J., Kallil, A., Kipnis, E., Kollef, M., Laupland, K., Paiva, J.-A., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05520-5 · Cited by 266
Acinetobacter baumannii: a universal threat to public health?
Giamarellou, H., Antoniadou, A., & Kanellakopoulou, K. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.02.013 · Cited by 258
Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
Ramirez, M. S., Bonomo, R. A., & Tolmasky, M. E. (2020) · Biomolecules · doi:10.3390/biom10050720 · Cited by 244
Acinetobacter baumannii: biology and drug resistance — role of carbapenemases
Nowak, P., & Paluchowska, P. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2016.0009 · Cited by 238
A Review on Bacterial Resistance to Carbapenems: epidemiology, Detection and Treatment Options
Elshamy, A. A., & Aboshanab, K. M. (2020) · Future Science OA · doi:10.2144/fsoa-2019-0098 · Cited by 238
Viehman, J. A., Nguyen, M. H., & Doi, Y. (2014) · Drugs · doi:10.1007/s40265-014-0267-8 · Cited by 215
Self-citationUnderstanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories
Humphries, R. M., Abbott, A. N., & Hindler, J. A. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00203-19 · Cited by 193
Vrancianu, C. O., Gheorghe, I., Czobor, I. B., & Chifiriuc, M. C. (2020) · Microorganisms · doi:10.3390/microorganisms8060935 · Cited by 188
Task force on management and prevention of Acinetobacter baumannii infections in the ICU
Garnacho-Montero, J., Dimopoulos, G., Poulakou, G., Akova, M., Cisneros, J. M., De Waele, J., Petrosillo, N., Seifert, H., Timsit, J. F., Vila, J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4079-4 · Cited by 167
Kempf, M., Bakour, S., Flaudrops, C., Berrazeg, M., Brunel, J.-M., Drissi, M., Mesli, E., Touati, A., & Rolain, J.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031676 · Cited by 165
Comparative Analysis of the Two Acinetobacter baumannii Multilocus Sequence Typing (MLST) Schemes
Gaiarsa, S., Batisti Biffignandi, G., Esposito, E. P., Castelli, M., Jolley, K. A., Brisse, S., Sassera, D., & Zarrilli, R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00930 · Cited by 163
Ertapenem, the first of a new group of carbapenems
SHAH, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg404 · Cited by 158
Silva, G., & Domingues, S. (2016) · Microorganisms · doi:10.3390/microorganisms4030029 · Cited by 151
Abbott, I. J., Cerqueira, G. M., Bhuiyan, S., & Peleg, A. Y. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.21 · Cited by 147
Greene, C., Vadlamudi, G., Newton, D. W., Foxman, B., & Xi, C. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.12.012 · Cited by 147
Mugnier, P. D., Poirel, L., & Nordmann, P. (2009) · Journal of Bacteriology · doi:10.1128/jb.01258-08 · Cited by 145
Acinetobacter baumannii: An Emerging Multidrug-Resistant Pathogen in Critical Care
Montefour, K., Frieden, J., Hurst, S., Helmich, C., Headley, D., Martin, M., & Boyle, D. A. (2008) · Critical Care Nurse · doi:10.4037/ccn2008.28.1.15 · Cited by 144
Weinberg, S. E., Villedieu, A., Bagdasarian, N., Karah, N., Teare, L., & Elamin, W. F. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100077 · Cited by 132
Carbapenem-resistantAcinetobacter baumannii: epidemiology, surveillance and management
Pogue, J. M., Mann, T., Barber, K. E., & Kaye, K. S. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.14 · Cited by 121
Hsueh, S.-C., Lee, Y., Huang, Y., Liao, C., Tsuji, M., & Hsueh, P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky425 · Cited by 108
New developments in carbapenems
Kattán, J. N., Villegas, M. V., & Quinn, J. P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02101.x · Cited by 107
Leungtongkam, U., Thummeepak, R., Tasanapak, K., & Sitthisak, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208468 · Cited by 105
Infections Due to Acinetobacter baumannii in the ICU: Treatment Options
Zhanel, G. G., Clark, N. M., & Lynch, J. P. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1599225 · Cited by 89
Butler, D. A., Biagi, M. J., Tan, X., Qasmieh, S., Bulman, Z. P., & Wenzler, E. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0706-5 · Cited by 84
Ayobami, O., Willrich, N., Suwono, B., Eckmanns, T., & Markwart, R. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-020-00750-5 · Cited by 83
Seifert, H., Müller, C., Stefanik, D., Higgins, P. G., Miller, A. A., & Kresken, M. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa208 · Cited by 82
Ben‐Chetrit, E., Weil‐Weiner, Y., Lesho, E. P., Kopuit, P., Broyer, C., Bier, L., Assous, M. V., Benenson, S., Cohen, M. J., McGann, P., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2247-y · Cited by 76
Tal-Jasper, R., Katz, D. E., Amrami, N., Ravid, D., Avivi, D., Zaidenstein, R., Lazarovitch, T., Dadon, M., Kaye, K. S., & Marchaim, D. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02656-15 · Cited by 68
Enfield, K. B., Huq, N. N., Gosseling, M. F., Low, D. J., Hazen, K. C., TONEY, D. M., Slitt, G., Zapata, H. J., Cox, H. L., Lewis, J. D., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/676857 · Cited by 65
Lima, W. G., Alves, G. C. D. S., Sanches, C., Fernandes, S. O. A., & de Paiva, M. C. (2019) · Burns · doi:10.1016/j.burns.2019.07.006 · Cited by 63
Shah, P. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01868.x · Cited by 52
New putative vaccine candidates against Acinetobacter baumannii using the reverse vaccinology method
Fereshteh, S., Abdoli, S., Shahcheraghi, F., Ajdary, S., Nazari, M., & Badmasti, F. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104114 · Cited by 51
Carbapenem use in critically ill patients
Patrier, J., & Timsit, J. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000622 · Cited by 49
program, I. R. O. A. B. E., Valencia, R., González-Galán, V., Alvarez-Marín, R., Cazalla-Foncueva, A. M., Aldabó, T., Gil-Navarro, M. V., Alonso-Araujo, I., Martin, C., Gordon, R., et al. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0658-4 · Cited by 47
The role of carbapenems in initial therapy for serious Gram-negative infections
Rahal, J. J. (2008) · Critical Care · doi:10.1186/cc6821 · Cited by 46
Dagher, M. M., Ruffin, F., Marshall, S. H., Taracila, M. A., Bonomo, R. A., Reilly, R. M., Fowler, V. G., & Thaden, J. T. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa150 · Cited by 45
Investigating Bacteriophages Targeting the Opportunistic Pathogen Acinetobacter baumannii
Styles, K. M., Thummeepak, R., Leungtongkam, U., Smith, S. E., Christie, G. S., Millard, A. D., Moat, J., Dowson, C. G., Wellington, E. M. H., Sitthisak, S., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9040200 · Cited by 41
Raible, K. M., Sen, B., Law, N., Bias, T. E., Emery, C. L., Ehrlich, G. D., & Joshi, S. G. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-017-0248-3 · Cited by 40
Self-citationLi, S., Chen, D.-Q., Ji, L., Sun, S., Jin, Z., Jin, Z.-L., Sun, H., Zeng, H., Zhang, W., Lu, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01069 · Cited by 39
Yoon, Y. K., Yang, K., Lee, S. E., Kim, H. J., Sohn, J. W., & Kim, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099101 · Cited by 38
Mahamat, A., Bertrand, X., Moreau, B., Hommel, D., Couppié, P., Simonnet, C., Kallel, H., Demar, M., Djossou, F., & Nacher, M. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.03.006 · Cited by 38
Metan, G., Zarakolu, P., Otlu, B., Tekin, İ., Aytaç, H., Bölek, E. Ç., Metin, B. C., Arsava, E. M., & Ünal, S. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.09.013 · Cited by 28
Studies on Acinetobacter baumannii involving multiple mechanisms of carbapenem resistance
Sen, B., & Joshi, S. G. (2015) · Journal of Applied Microbiology · doi:10.1111/jam.13037 · Cited by 26
Self-citationBansal, G., Allen-McFarlane, R., & Eribo, B. E. (2020) · International Journal of Microbiology · doi:10.1155/2020/2120159 · Cited by 26
D’Souza, R., Pinto, N. A., Phuong, N. L., Higgins, P. G., Vu, T. N., Byun, J., Cho, Y. L., Choi, J. R., & Yong, D. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00559 · Cited by 24
Mujawar, S., Mishra, R., Pawar, S., Gatherer, D., & Lahiri, C. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00203 · Cited by 21
Tahri, A., Ksouda, K., Kallel, R., Daoud, S., Boudawara, T. S., Zeghal, K. M., & Sahnoun, Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.039 · Cited by 17
van Almsick, V. F., Ghebremedhin, B., Pfennigwerth, N., & Ahmad‐Nejad, P. (2018) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2018.02.004 · Cited by 16
Jing, X., Min, X., Zhang, X., Gong, L., Wu, T., Sun, R., Chen, L., Liu, R., & Zeng, J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00371 · Cited by 16
Cited by
Treatment of Acinetobacter baumannii severe infections
Reina, R., León-Moya, C., & Garnacho-Montero, J. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.08.007 · Cited by 22
Metadata
- Authors
- Nguyen, M., & Joshi, S. G.
- Venue
- Journal of Applied Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-21
- Volume
- 131
- Issue
- 6
- Pages
- 2715-2738
- ISSN
- 1364-5072 (ISSN-L)
- 1365-2672
- OpenAlex
- W3162964998
- Cited by
- 259
- References
- 78
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.